Page 64 - Read Online
P. 64

Page 10 of 11        Calderon Novoa et al. Hepatoma Res 2023;9:33  https://dx.doi.org/10.20517/2394-5079.2023.36

               34.      Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical outcome and prognostic factors in intrahepatic
                   cholangiocarcinoma. World J Surg 2008;32:2675-80.  DOI  PubMed
               35.      Lang H, Baumgart J, Heinrich S, et al. Liver resection for intrahepatic cholangiocarcinoma-single-center experience with 286 patients
                   undergoing surgical exploration over a thirteen year period. J Clin Med 2021;10:3559.  DOI  PubMed  PMC
               36.      Sotiropoulos GC, Bockhorn M, Sgourakis G, et al. R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a
                   diagnosis-related analysis. Dig Dis Sci 2009;54:887-94.  DOI
               37.      Si A, Li J, Yang Z, et al. Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients
                   with intrahepatic cholangiocarcinoma. Ann Surg Oncol 2019;26:1841-50.  DOI
               38.      Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI. What prognostic factors are important for resected intrahepatic
                   cholangiocarcinoma? J Gastroenterol Hepatol 2008;23:766-70.  DOI  PubMed
               39.      Becker  NS,  Rodriguez  JA,  Barshes  NR,  O'Mahony  CA,  Goss  JA,  Aloia  TA.  Outcomes  analysis  for  280  patients  with
                   cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 2008;12:117-22.  DOI  PubMed
               40.      Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993;166:768-71;
                   discussion 771.  DOI
               41.      O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive
                   patients. Ann Surg 1988;207:373-9.  DOI  PubMed  PMC
               42.      Yokoyama I, Todo S, Iwatsuki S, Starzl TE. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology
                   1990;37:188-93.  PubMed  PMC
               43.      Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000;69:1633-7.
                   DOI  PubMed
               44.      Shimoda M, Farmer DG, Colquhoun SD, et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center
                   experience and review of the literature. Liver Transpl 2001;7:1023-33.  DOI
               45.      Robles R, Figueras J, Turrión VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann
                   Surg 2004;239:265-71.  DOI  PubMed  PMC
               46.      Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.
                   Liver Transpl 2005;11:1412-6.  DOI
               47.      Vilchez V, Shah MB, Daily MF, et al. Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular
                   carcinoma and cholangiocarcinoma: an analysis of the UNOS database. HPB 2016;18:29-34.  DOI  PubMed  PMC
               48.      Sapisochin G, Rodríguez de Lope C, Gastaca M, et al. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver
                   transplantation be reconsidered in these patients? Am J Transplant 2014;14:660-7.  DOI
               49.      Sapisochin G, Facciuto M, Rubbia-Brandt L, et al; iCCA International Consortium. Liver transplantation for "very early" intrahepatic
                   cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology 2016;64:1178-88.  DOI
               50.      Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc 1988;20:478-82.  PubMed
               51.      Sotiropoulos GC, Kaiser GM, Lang H, et al. Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a
                   single-center experience. Transplant Proc 2008;40:3194-5.  DOI
               52.      Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol
                   2022;76:681-93.  DOI  PubMed  PMC
               53.      Gores GJ, Darwish Murad S, Heimbach JK, Rosen CB. Liver transplantation for perihilar cholangiocarcinoma. Dig Dis 2013;31:126-9.
                   DOI  PubMed
               54.      Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A; OLT for HCC Consensus Group. Recommendations for liver
                   transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2012;13:e11-22.  DOI
                   PubMed  PMC
               55.      Sapisochin G, Javle M, Lerut J, et al. Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma:
                   working group report from the ILTS transplant oncology consensus conference. Transplantation 2020;104:1125-30.  DOI
               56.      Liver Transplantation for Early Intrahepatic Cholangiocarcinoma (LT for iCCA). Available from: https://clinicaltrials.gov/ct2/show/
                   NCT02878473 [Last accessed on 27 Jul 2023].
               57.      Ziogas IA, Giannis D, Economopoulos KP, et al. Liver transplantation for intrahepatic cholangiocarcinoma: a meta-analysis and meta-
                   regression of survival rates. Transplantation 2021;105:2263-71.  DOI
               58.      Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with
                   cirrhosis. N Engl J Med 1996;334:693-9.  DOI
               59.      Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not
                   adversely impact survival. Hepatology 2001;33:1394-403.  DOI
               60.      Takahashi K, Obeid J, Burmeister CS, et al. Intrahepatic cholangiocarcinoma in the liver explant after liver transplantation: histological
                   differentiation and prognosis. Ann Transplant 2016;21:208-15.  DOI
               61.      De Martin E, Rayar M, Golse N, et al. Analysis of liver resection versus liver transplantation on outcome of small intrahepatic
                   cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis. Liver Transpl 2020;26:785-98.  DOI
               62.      Rayar M, Sulpice L, Edeline J, et al. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising
                   method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Ann Surg Oncol 2015;22:3102-8.
                   DOI
   59   60   61   62   63   64   65   66   67   68   69